Harigopal Sandhyavenu
Overview
Explore the profile of Harigopal Sandhyavenu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
102
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ullah W, Sandhyavenu H, Zaidi S, Alonso M, Khan M, Ullah I, et al.
JACC Adv
. 2025 Feb;
4(3):101600.
PMID: 39970740
Background: The utility of polymer-permanent, polymer-absorbable, and polymer-free drug-eluting stents (DES) in the context of different eluting drugs in patients undergoing percutaneous coronary intervention (PCI) remains controversial. Objectives: The purpose...
2.
Neppala S, Chigurupati H, Fath A, Jagirdhar G, Sandhyavenu H, Bolte J, et al.
Cardiovasc Revasc Med
. 2025 Jan;
PMID: 39765439
Background: Pulmonary hypertension (pHTN) has been associated with increased morbidity and mortality after mitral Transcatheter Edge-to-Edge Repair (TEER), but the association remains uncertain. This study aims to evaluate the impact...
3.
Kumar R, Hallemeier C, Chang D, Lu S, Hathout L, Hristidis V, et al.
J Natl Cancer Inst
. 2024 Dec;
PMID: 39626307
Background: Anal squamous cell carcinoma (ASCC) is a rare cancer with increased occurrence of multiple cancers before and after the ASCC diagnosis. However, there is limited data on this aspect....
4.
Ullah W, Sandhyavenu H, Taha A, Narayana Gowda S, Mukhtar M, Polam A, et al.
J Am Heart Assoc
. 2024 Oct;
13(20):e032490.
PMID: 39392170
Background: Optimal duration and choice of antiplatelet therapy in patients with acute coronary syndrome undergoing percutaneous coronary intervention remain controversial. Methods And Results: Digital databases (PubMed, Cochrane, and Embase) were...
5.
Thyagaturu H, Sandhyavenu H, Titus A, Roma N, Gonuguntla K, Patel N, et al.
Korean Circ J
. 2024 Aug;
54(11):710-723.
PMID: 39175340
Background And Objectives: There are limited national data on the trends and outcomes of patients hospitalized with acute myocardial infarction (AMI) during the coronavirus disease 2019 (COVID-19) pandemic. We aimed...
6.
Thyagaturu H, Taha A, Ali S, Roma N, Duhan S, Patel N, et al.
Am J Cardiovasc Dis
. 2024 Jul;
14(3):153-171.
PMID: 39021522
Background: Disparities in acute myocardial infarction (AMI)-related outcomes have been reported before the COVID-19 pandemic. We studied in-hospital outcomes of AMI across demographic groups in the United States during the...
7.
Ullah W, Thalambedu N, Zahid S, Muhammadzai H, Sandhyavenu H, Kumar A, et al.
JACC Adv
. 2024 Jun;
2(1):100167.
PMID: 38939027
Background: Patients with severe aortic stenosis and cancer are often denied surgical aortic valve replacement (SAVR) due to a prohibitive risk of perioperative mortality. Objectives: The purpose of this study...
8.
Gonuguntla K, Badu I, Duhan S, Sandhyavenu H, Chobufo M, Taha A, et al.
J Am Heart Assoc
. 2024 Jun;
13(12):e033515.
PMID: 38842272
Background: The incidence of premature myocardial infarction (PMI) in women (<65 years and men <55 years) is increasing. We investigated proportionate mortality trends in PMI stratified by sex, race, and...
9.
Taha A, Badu I, Sandhyavenu H, Victor V, Duhan S, Atti L, et al.
Expert Rev Cardiovasc Ther
. 2023 Jul;
21(8):601-608.
PMID: 37409406
Background: The role of oral anticoagulation during the COVID-19 pandemic has been debated widely. We studied the clinical outcomes of COVID-19 hospitalizations in patients who were on long-term anticoagulation. Research...
10.
Thotamgari S, Sheth A, Patel H, Sandhyavenu H, Patel B, Grewal U, et al.
Postgrad Med
. 2023 May;
135(6):562-568.
PMID: 37224412
Background: Atrial fibrillation (AF) is the most common arrhythmia in patients with cancer, especially breast, gastrointestinal, respiratory, urinary tract, and hematological malignancies. Catheter ablation (CA) is a well-established, safe treatment...